NutraLife BioSciences, Inc. engages in the development, manufacture, and distribution of nutritional and dietary oral spray products. Its private label products include cannabidiol-infused oral sprays, tinctures, pet drops, pain balms, and face creams; and nutraceutical oral spray products for sleep support and weight loss packaged under the customer's brand names. The company was founded by Edgar Jason Ward on April 1, 2010 and is headquartered in Coconut Creek, FL.
Company profile
Ticker
NLBS
Exchange
Website
CEO
Edgar Jason Ward
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Dean Foods • Lifeway Foods • Trident Brands • Sipup • Nutranomics • Artisanal Brands • Energy 1 • Burcon NutraScience ...
Former names
NUTRAFUELS INC
SEC CIK
Corporate docs
Subsidiaries
Precision Analytic Testing, LLC • NutraDerma Technologies, Inc. • PhytoChem Technologies, Inc. • TransDermalRX, Inc. ...
NLBS stock data
Latest filings (excl ownership)
NT 10-K
Notice of late annual filing
31 Mar 23
8-K
Entry into a Material Definitive Agreement
28 Feb 23
10-Q
2022 Q3
Quarterly report
21 Nov 22
NT 10-Q
Notice of late quarterly filing
14 Nov 22
8-K
Entry into a Material Definitive Agreement
12 Oct 22
10-Q
2022 Q2
Quarterly report
22 Aug 22
8-K
Changes in Registrant's Certifying Accountant
17 Aug 22
NT 10-Q
Notice of late quarterly filing
15 Aug 22
10-Q
2022 Q1
Quarterly report
23 May 22
NT 10-Q
Notice of late quarterly filing
16 May 22
Financial summary
Quarter (USD) | Sep 22 | Jun 22 | Mar 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 431.71 k | 431.71 k | 431.71 k | 431.71 k | 431.71 k | 431.71 k |
Cash burn (monthly) | (no burn) | (no burn) | 392.66 k | 302.86 k | 146.65 k | 55.79 k |
Cash used (since last report) | n/a | n/a | 7.33 mm | 5.66 mm | 2.74 mm | 1.04 mm |
Cash remaining | n/a | n/a | -6.90 mm | -5.22 mm | -2.31 mm | -610.14 k |
Runway (months of cash) | n/a | n/a | -17.6 | -17.3 | -15.7 | -10.9 |